Eli Lilly, Novo Nordisk tumble after Hims & Hers announce Wegovy copy
Weight-loss drugmakers Eli Lilly and Novo Nordisk fell after telehealth company Hims & Hers announced Thursday it will offer a copy of the newly launched Wegovy pill for $49, far less than the $149 Novo sells the branded pill for. Copenhagen-listed shares of Novo dropped 7% on the news, while Eli Lilly stock fell 6.1%…